Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 63

1.

Investigation of the cause of death in a gene-therapy trial.

Frank KM, Hogarth DK, Miller JL, Mandal S, Mease PJ, Samulski RJ, Weisgerber GA, Hart J.

N Engl J Med. 2009 Jul 9;361(2):161-9. doi: 10.1056/NEJMoa0801066.

PMID:
19587341
[PubMed - indexed for MEDLINE]
Free Article
2.

Gene therapy--still a work in clinical and regulatory progress.

Hohmann EL.

N Engl J Med. 2009 Jul 9;361(2):193-5. doi: 10.1056/NEJMe0902716. No abstract available.

PMID:
19587346
[PubMed - indexed for MEDLINE]
3.

Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study.

Mease PJ, Wei N, Fudman EJ, Kivitz AJ, Schechtman J, Trapp RG, Hobbs KF, Greenwald M, Hou A, Bookbinder SA, Graham GE, Wiesenhutter CW, Willis L, Ruderman EM, Forstot JZ, Maricic MJ, Dao KH, Pritchard CH, Fiske DN, Burch FX, Prupas HM, Anklesaria P, Heald AE.

J Rheumatol. 2010 Apr;37(4):692-703. doi: 10.3899/jrheum.090817. Epub 2009 Dec 23.

PMID:
20032102
[PubMed - indexed for MEDLINE]
4.

Clinical trials. Gene transfer an unlikely contributor to patient's death.

Kaiser J.

Science. 2007 Dec 7;318(5856):1535. No abstract available.

PMID:
18063761
[PubMed - indexed for MEDLINE]
5.

Death in a gene-therapy trial.

Hage CA, Bowyer S, Kleiman MB.

N Engl J Med. 2009 Oct 29;361(18):1811-2. No abstract available.

PMID:
19877311
[PubMed - indexed for MEDLINE]
6.

Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study.

Mease PJ, Hobbs K, Chalmers A, El-Gabalawy H, Bookman A, Keystone E, Furst DE, Anklesaria P, Heald AE.

Ann Rheum Dis. 2009 Aug;68(8):1247-54. doi: 10.1136/ard.2008.089375. Epub 2008 Aug 4.

PMID:
18678578
[PubMed - indexed for MEDLINE]
7.

Gene therapy. Questions remain on cause of death in arthritis trial.

Kaiser J.

Science. 2007 Sep 21;317(5845):1665. No abstract available.

PMID:
17885103
[PubMed - indexed for MEDLINE]
8.

Fatal Histoplasma capsulatum mitral endocarditis in a French patient treated for rheumatoid arthritis.

Letranchant L, Debourgogne A, Doco-Lecompte T, Contet-Audonneau N, May T, Machouart M.

Mycopathologia. 2012 Mar;173(2-3):183-6. doi: 10.1007/s11046-011-9489-4. Epub 2011 Oct 30.

PMID:
22042634
[PubMed - indexed for MEDLINE]
9.

Reactivation histoplasmosis after treatment with anti-tumor necrosis factor alpha in a patient from a nonendemic area.

Jain VV, Evans T, Peterson MW.

Respir Med. 2006 Jul;100(7):1291-3. Epub 2006 Mar 20.

PMID:
16545951
[PubMed - indexed for MEDLINE]
Free Article
10.

Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept.

Lee JH, Slifman NR, Gershon SK, Edwards ET, Schwieterman WD, Siegel JN, Wise RP, Brown SL, Udall JN Jr, Braun MM.

Arthritis Rheum. 2002 Oct;46(10):2565-70.

PMID:
12384912
[PubMed - indexed for MEDLINE]
Free Article
11.

Disseminated Histoplasma capsulatum infection presenting with panniculitis and focal myositis in rheumatoid arthritis treated with etanercept.

Bourré-Tessier J, Fortin C, Belisle A, Desmarais E, Choquette D, Senécal JL.

Scand J Rheumatol. 2009;38(4):311-6. doi: 10.1080/03009740902776935. Review.

PMID:
19444717
[PubMed - indexed for MEDLINE]
12.

Atypical presentation of histoplasmosis in a patient with psoriasis and psoriatic arthritis on infliximab therapy.

Kamili Qu, Menter A.

J Drugs Dermatol. 2010 Jan;9(1):57-60.

PMID:
20120426
[PubMed - indexed for MEDLINE]
13.

[Infectious risks of immunomodulating therapies in rheumatology].

Van Delden C.

Rev Med Suisse. 2006 Mar 15;2(57):738-40, 743-5. Review. French.

PMID:
16604876
[PubMed - indexed for MEDLINE]
14.

Lethal acute respiratory distress syndrome during anti-TNF-alpha therapy for rheumatoid arthritis.

Zimmer C, Beiderlinden M, Peters J.

Clin Rheumatol. 2006 May;25(3):430-2. Epub 2005 Oct 1.

PMID:
16200383
[PubMed - indexed for MEDLINE]
15.

Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.

Hyrich KL, Watson KD, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register.

Rheumatology (Oxford). 2006 Dec;45(12):1558-65. Epub 2006 May 16.

PMID:
16705046
[PubMed - indexed for MEDLINE]
Free Article
16.

Septic arthritis caused by Actinobacillus ureae in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor-alpha therapy.

Kaur PP, Derk CT, Chatterji M, Dehoratius RJ.

J Rheumatol. 2004 Aug;31(8):1663-5.

PMID:
15290751
[PubMed - indexed for MEDLINE]
17.

Fatal pulmonary Mycobacterium xenopi in a patient with rheumatoid arthritis receiving etanercept.

Maimon N, Brunton J, Chan AK, Marras TK.

Thorax. 2007 Aug;62(8):739-40.

PMID:
17687101
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy.

Kroesen S, Widmer AF, Tyndall A, Hasler P.

Rheumatology (Oxford). 2003 May;42(5):617-21.

PMID:
12709536
[PubMed - indexed for MEDLINE]
Free Article
20.

Intraarticular gene transfer of TNFR:Fc suppresses experimental arthritis with reduced systemic distribution of the gene product.

Chan JM, Villarreal G, Jin WW, Stepan T, Burstein H, Wahl SM.

Mol Ther. 2002 Dec;6(6):727-36.

PMID:
12498769
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk